More Clinical Articles


Successful Pharmacovigilance: Harnessing Relationships between Stakeholders

Dr Nicola Davies, (Apr 16, 2015)

What makes pharmacovigilance effective and efficient is the trust between the different parties and stakeholders.

4 Ways to Guarantee your Trials Become More Patient-Centric

Zuzanna Fimińska, (Apr 16, 2015)

Could trials be at risk of being invalidated by rebellion from patients?

Risk Sharing Agreements on the American Horizon

Danielle Barron, (Apr 16, 2015)

US stakeholders are beginning to consider risk sharing agreements, but to what effect?

Alzheimer’s: Can we save the world from a public health disaster?

Zuzanna Fimińska, (Apr 2, 2015)

Alzheimer’s disease is a ticking time bomb for public health around the world. If we don’t act now, it will single-handedly devastate global healthcare systems.

Partnership: The Game Changer in Alzheimer’s Research

Danielle Barron, (Apr 1, 2015)

A unique public-private partnership aims to change the face of Alzheimer’s dementia research by avoiding the duplication of research efforts. Danielle Barron speaks to those involved to find out why this new approach may finally lead to effective treatments for the condition.

Patient Centered Clinical Trials

Dr Nicola Davies, (Mar 30, 2015)

As pharmaceutical companies compete to bring new drugs to market, there is an increasing emphasis on the need for patient centricity – to retain patient volunteers and produce quality data. We spoke to Duncan Cantor, Director of Communications, Boehringer Ingelheim, about the importance of patient centricity in clinical trials.

Time to flourish

Adam Hill, (Mar 22, 2015)

Failure is going to be part of the process with biosimilars, but for companies with an entrepreneurial spirit and a clear mindset, the rewards are also there...

GSK Clinical Trial Questionnaire: Most Valuable Patient Initiative

Adam Hill, (Mar 20, 2015)

A move towards greater patient centricity was behind GSK's desire to get systematic feedback from participants in clinical trials – and the company hopes its blueprint can be taken up by rivals.

Engineering a Culture of Innovation Part 2: Social Contracts

Dr Nicola Davies, (Mar 19, 2015)

Continuing the recent interview with Henry Doss, ecosystem architect and co-author of ‘The Rainforest Scorecard: A Practical Framework for Growing Innovation Potential', we now look more closely at the elements of engineering a culture of innovation.

Size Matters

Des Sampson, (Mar 17, 2015)

Dr Robert Langer was the recent recipient of the Queen Elizabeth Prize in Engineering, for his groundbreaking research into controlled, targeted drug delivery. eyeforpharma unravels his past achievements, discusses his present research and offers his future vision of medicine.